SIRT1 and acute lymphoblastic leukemia: SIRT1 KO T-ALL recipients exhibited lower GFP+ cell percentages and white blood cell counts than SIRT1 WT T-ALL recipients by peripheral blood monitoring (Fig. 4b, c).